Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | INPP5A | Q14642 | 1/20 | 0.40 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.36 |
| ▸ | FBP1 | P09467 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7798872 | 0.81 | SMPD1 (0.50) | INPP5A | |
| SCHEMBL4191662 | 0.81 | SMPD1 (0.50) | INPP5A | |
| SCHEMBL4442196 | 0.81 | SMPD1 (0.50) | INPP5A | |
| SCHEMBL23665561 | 0.79 | MAPK1 (0.33) | SLC2A1FBP1 | |
| SCHEMBL30412792 | 0.76 | ITPR3 (0.52) | INPP5A | |
| SCHEMBL8859419 | 0.76 | ITPR3 (0.52) | INPP5A | |
| SCHEMBL6393369 | 0.75 | FBP1 (0.37) | SLC2A1FBP1 | |
| SCHEMBL23665560 | 0.73 | FBP1 (0.35) | SLC2A1FBP1 | |
| SCHEMBL30237668 | 0.72 | SMPD1 (0.54) | INPP5A | |
| SCHEMBL16351395 | 0.72 | L3MBTL1 (0.46) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210222165-A1 | Chemically Ligated RNAs for CRISPR/Cas9-lgRNA Complexes as Antiviral Therapeutic Agents | DR MINGHONG ZHONG (US) | 2021-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210222165-A1 | Chemically Ligated RNAs for CRISPR/Cas9-lgRNA Complexes as Antiviral Therapeutic Agents | TRDMT1, SRRT, ZFR | INPP5A 4314/4885SLC2A1 4416/4885FBP1 3231/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.